Lyse now, stent later: the grace of GRACIA

Affiliations

Comment

Freek W A Verheugt. Lancet. 2004 Sep.

. 2004 Sep;364(9439):1014-5.

doi: 10.1016/S0140-6736(04)17072-4.

¹ Heartcentre, 540 Department of Cardiology, University Medical Centre, St Radboud, 6500 HB Nijmegen, Netherlands. f.verheugt@cardio.umcn.nl

No abstract available

Comment on

GUSTO V: the bottom line of fibrinolytic reperfusion therapy.
Verheugt FW. Verheugt FW. Lancet. 2001 Jun 16;357(9272):1898-9. doi: 10.1016/S0140-6736(00)05087-X. Lancet. 2001. PMID: 11425404 No abstract available.
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
Keeley EC, Boura JA, Grines CL. Keeley EC, et al. Lancet. 2003 Jan 4;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7. Lancet. 2003. PMID: 12517460 Review.
Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.
Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, Vázquez N, Blanco J, Alonso-Briales J, López-Mesa J, Fernández-Vazquez F, Calvo I, Martínez-Elbal L, San Román JA, Ramos B; GRACIA (Grupo de Análisis de la Cardiopatía Isquémica Aguda) Group. Fernandez-Avilés F, et al. Lancet. 2004 Sep 18-24;364(9439):1045-53. doi: 10.1016/S0140-6736(04)17059-1. Lancet. 2004. PMID: 15380963 Clinical Trial.